Massimo Breccia

Pubblicazioni

Titolo Pubblicato in Anno
Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure THE NEW ENGLAND JOURNAL OF MEDICINE 2019
Observational study of chronic myeloid leukemia Italian patients who discontinued tyrosine kinase inhibitors in clinical practice HAEMATOLOGICA 2019
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP BLOOD ADVANCES 2019
Can Chronic-Phase Chronic Myeloid Leukemia Patients Achieve Optimal and Durable Responses after Two Failed TKI Treatments? Real-World Evidence Data ACTA HAEMATOLOGICA 2019
A journey through infectious risk associated with ruxolitinib BRITISH JOURNAL OF HAEMATOLOGY 2019
Deferasirox in the treatment of iron overload during myeloproliferative neoplasms in fibrotic phase: does ferritin decrement matter? LEUKEMIA RESEARCH 2019
Treatment Patterns in Patients with Chronic-Phase Chronic Myeloid Leukaemia in Routine Clinical Practice: the SIMPLICITY Italian Population MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES 2019
Outcome of very elderly chronic myeloid leukaemia patients treated with imatinib frontline ANNALS OF HEMATOLOGY 2019
Efficacy and safety of ruxolitinib and hydroxyurea combination in patients with hyperproliferative myelofibrosis ANNALS OF HEMATOLOGY 2019
Next-generation sequencing for BCR-ABL1 kinase domain mutation testing in patients with chronic myeloid leukemia: a position paper JOURNAL OF HEMATOLOGY & ONCOLOGY 2019
Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology SEMINARS IN ONCOLOGY 2019
Digital droplet PCR at the time of TKI discontinuation in chronic-phase chronic myeloid leukemia patients is predictive of treatment-free remission outcome HEMATOLOGICAL ONCOLOGY 2019
Current Information and Recommendations on the Discontinuation of TKI Inhibitors in Chronic Myeloid Leukemia CURRENT ONCOLOGY REPORTS 2018
Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia ANNALS OF HEMATOLOGY 2018
Differential proteomic profile of leukemic CD34+ progenitor cells from chronic myeloid leukemia patients ONCOTARGET 2018
Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes LEUKEMIA RESEARCH 2018
Changes in estimated glomerular filtration rate in chronic myeloid leukemia patients treated front line with available TKIs and correlation with cardiovascular events ANNALS OF HEMATOLOGY 2018
Low-Dose Ponatinib in Intolerant Chronic Myeloid Leukemia Patients: A Safe and Effective Option CLINICAL DRUG INVESTIGATION 2018
Novel tyrosine-kinase inhibitors for the treatment of chronic myeloid leukemia: safety and efficacy EXPERT REVIEW OF HEMATOLOGY 2018
Association between proteomic profile and molecular response in chronic myeloid leukemia patients LEUKEMIA & LYMPHOMA 2018

© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma